Related references
Note: Only part of the references are listed.Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials
Masaaki Mori et al.
Modern Rheumatology (2014)
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
Nicolino Ruperto et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Long-Term Safety and Effectiveness of Etanercept in Children With Selected Categories of Juvenile Idiopathic Arthritis
E. H. Giannini et al.
ARTHRITIS AND RHEUMATISM (2009)
Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
Daniel J. Lovell et al.
ARTHRITIS AND RHEUMATISM (2008)
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
Shumpei Yokota et al.
LANCET (2008)
Adalimumab with or without methotrexate in juvenile rheumatoid arthritis
Daniel J. Lovell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
Nicolino Ruperto et al.
ARTHRITIS AND RHEUMATISM (2007)
Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis
DJ Lovell et al.
ARTHRITIS AND RHEUMATISM (2006)
Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type
P Quartier et al.
ARTHRITIS AND RHEUMATISM (2003)
Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis - Interim results from an ongoing multicenter, open-label, extended-treatment trial
DJ Lovell et al.
ARTHRITIS AND RHEUMATISM (2003)
Share Paper
